Wegovy 7.2mg is a prescription-only injectable medicine containing semaglutide, a GLP-1 receptor agonist used alongside a reduced-calorie diet and increased physical activity to support weight management in eligible patients.
Wegovy works by mimicking a naturally occurring hormone called GLP-1 (glucagon-like peptide-1), which plays a role in appetite regulation, food intake and feelings of fullness.
The 7.2mg strength is part of the Wegovy dose escalation programme and is used under the guidance of a qualified healthcare professional.When prescribed appropriately alongside lifestyle changes, Wegovy may help eligible patients with:
Individual results vary, and treatment suitability should always be assessed by a healthcare professional.
Active Ingredient
Semaglutide – a GLP-1 receptor agonist.
Presentation
Administration
Wegovy is administered as a once-weekly subcutaneous injection.
Dose Progression
Treatment typically follows a gradual dose escalation schedule to help patients adjust to treatment.
Wegovy is prescribed as part of a weight management programme for eligible patients, including adults with:
Treatment should always be combined with:
Wegovy works by activating GLP-1 receptors in the body.
This may help to:
The medication works alongside lifestyle changes to support weight management.
